J VIRAL HEPATITIS 润色咨询

JOURNAL OF VIRAL HEPATITIS

出版年份：1994 年文章数：1796 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2020-02-07 wj1891a6d0fem

    直接拒稿大约十天左右，送审大约一个月左右有消息138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:
    1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？

    138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2022-03-08 1529826491

    偏重的研究方向：乙肝
    经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2021-12-29 乌云背后的幸福线

    期刊可以有几个通讯作者/第一作者？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    什么是correspondingauthor/通讯作者？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2021-10-24 andreazhaosdu

    请问各位有纯生信文章的投稿经验吗？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2021-08-02 kieris

    二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2021-05-07 ms6000000978581908

    偏重的研究方向： 乙型肝炎
    经验分享：有审稿三个多月了还在under review的朋友吗

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2018-04-25 Leopard FD

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2020-05-11 1861eaa8b6m

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=584354, encodeId=ec8e58435495, content=直接拒稿大约十天左右，送审大约一个月左右有消息<span class="quote">138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表:<br>1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？</span>, beContent=138kaGJ0864(暂无昵称) 2020-02-06 00:00:00 发表: 1.20投稿，已经半个多月了也没见任何动静，请问了解这个杂志的朋友，这杂志一般要多久才给拒不拒稿的消息哦？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/362aa705fa9598e43a7ada9699cd53f9.jpg, createdBy=b72d1677334, createdName=wj1891a6d0fem, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200630, encodeId=d280120063054, content=偏重的研究方向：乙肝<br>经验分享：有投稿2个月一直还是Under Review 的小伙伴吗？这样的Under Review是不是已经送审了呀？不知道该不该发邮件问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:01:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094422, encodeId=f5fa10944222e, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094421, encodeId=6859109442142, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063428, encodeId=815a1063428d8, content=请问各位有纯生信文章的投稿经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ceb4790255, createdName=andreazhaosdu, createdTime=Sun Oct 24 12:17:54 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004579, encodeId=065a10045e9d0, content=二月底投的文章，到现在也没给答复，中间催了编辑两次都说已经在审稿中，之前审稿没听说这么慢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=212f5455778, createdName=kieris, createdTime=Mon Aug 02 10:52:07 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963412, encodeId=eb4e96341238, content=偏重的研究方向： 乙型肝炎 <br>经验分享：有审稿三个多月了还在under review的朋友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2945398992, createdName=ms6000000978581908, createdTime=Fri May 07 15:11:25 CST 2021, time=2021-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555366, encodeId=e6cf5553664b, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：2月27号投稿.昨日收到邮件.直接接收!accept with minor revision , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=367, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Apr 25 00:00:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590662, encodeId=a0d759066210, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：3月24投，稿件号159，中间状态一直是with editor，直到5月11回复拒稿，说只接受20%的文章，推荐转投一个垃圾杂志，送了一个外审，提的4点意见，很无语，没有修改的可能性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906660, encodeId=dbaa90666062, content=投稿命中率:50.0<br>经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aafc2471844, createdName=zzzyyyxxx, createdTime=Thu Dec 10 11:03:04 CST 2020, time=2020-12-10, status=1, ipAttribution=)]
    2020-12-10 zzzyyyxxx

    投稿命中率:50.0
    经验分享：十一月4号投稿，十二月份十号仍然显示under review，看了一下 这个杂志分数掉的有点快呀 怎么回事儿

    1

    展开1条回复
共57条页码: 1/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分